Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
02/2008
02/13/2008CN100367946C Gabapentin analogues for fibromy algia and other disorders
02/13/2008CN100367944C Allicin microcapsule and its preparation method
02/13/2008CN100367939C Shangshan dripping pill for treating toxic heat and internal storage and its preparing method
02/13/2008CN100367938C Sihuang intense heat purging dripping pill and its preparing method
02/13/2008CN100367936C Oral drop pill in use for clearing sway heat and toxic material, relieving inflammation and dysentery, and preparation method
02/13/2008CN100367935C Oral drop pills in use for treating diseases of bacterial infection and preparation method
02/13/2008CN100367865C Method for preparing digestion-promoting spleen-invigorating soybean milk powder with micron chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder and pine pollen
02/13/2008CN100367864C Method for preparing intestine-moisturizing face-beautifying soybean milk tablet with micron pine pollen, cactus powder, ganoderma lucidum powder and wolferry fruit powder
02/12/2008US7329782 Compounds for the treatment of metabolic disorders
02/12/2008US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis
02/12/2008US7329761 Substituted imides
02/12/2008US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
02/12/2008US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof
02/12/2008US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain
02/12/2008US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound
02/12/2008US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
02/12/2008US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
02/12/2008US7329668 For therapy of inflammatory diseases, immune diseases, and cancer
02/12/2008US7329667 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor
02/12/2008US7329660 Phthalazine derivatives for treating inflammatory diseases
02/12/2008US7329651 Cannabimimetic ligands
02/12/2008CA2374003C Improved cellular uptake of bioactive agents
02/12/2008CA2346132C Antibacterial agents and process for producing the same
02/12/2008CA2317793C Laxative composition
02/12/2008CA2315261C Oral pharmaceutical extended release dosage form
02/12/2008CA2220140C (2-morpholinylmethyl)benzamide derivatives
02/12/2008CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics
02/07/2008WO2008016883A2 Inhibitors of plasma kallikrein
02/07/2008WO2008016175A1 Activator for peroxisome proliferator activated receptor
02/07/2008WO2008016132A1 Benzyl phenyl glucopyranoside derivative
02/07/2008WO2008016118A1 Agent targeting dopamine receptor and screening method therefor
02/07/2008WO2008016107A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
02/07/2008WO2008015850A1 Composition for prevention and amelioration of metabolic syndrome
02/07/2008WO2008015763A1 Drug formulation containing fibrate medicament and process for producing the same
02/07/2008WO2008015196A1 5-,7-bis-substituted imidazo[1,2-a]pyridines
02/07/2008WO2008014564A1 Methods and compositions for inhibiting angiogenesis
02/07/2008WO2007124734A3 Compounds a-r-x for the manufacture of pharmaceutical preparations
02/07/2008US20080033170 Novel compounds
02/07/2008US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders
02/07/2008US20080033061 Cation conducting gabaa receptors and their use
02/07/2008US20080033033 8-azaprostaglandin derivatives and medical use thereof
02/07/2008US20080033029 Treating Digestive Tract Conditions
02/07/2008US20080033013 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation
02/07/2008US20080033006 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors
02/07/2008US20080032998 Pyrazolopyrimidines, a process for their preparation and their use as medicine
02/07/2008US20080032969 Novel compounds
02/07/2008US20080032959 Estrogen Receptor Modulators
02/07/2008US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds
02/07/2008US20080032918 Gene expression or biosynthesis inhibition by locally administering inhibitors of angiotensin-converting enzyme, angiotensin type 1 receptors, or sodium-hydrogen exchange type-1 proteins; antiinflammatory agents, myocardial antiischemic agents, anaphylaxis; sustained release implants, stents, inhalers
02/07/2008US20080031984 Compositions and Methods for Treating or Preventing Inflammatory Bowel Disease, Familial Adenomatous Polyposis and Colon Cancer
02/07/2008US20080031983 Method for Treatment of Constipation-Predominant Irritable Bowel Syndrome
02/07/2008US20080031972 Process For Manufacturing Spherical Activated Carbon
02/07/2008US20080031941 Gastric acid secretion inhibiting composition
02/07/2008US20080031936 Immunostimulatory nucleic acid molecules
02/07/2008US20080031875 Treatment method
02/07/2008US20080031860 Compositions Comprising Pantothenic Acid or Derivatives Thereof and Their Use for Stimulating Appetite
02/07/2008US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders
02/07/2008CA2659835A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
02/07/2008CA2659542A1 Methods and compositions for inhibiting angiogenesis
02/07/2008CA2657394A1 Preparation containing fibrate agent and process for producing the same
02/07/2008CA2649044A1 Benzylphenyl glucopyranoside derivative
02/06/2008EP1884240A1 Pharmaceutical for prevention or treatment of bone metabolic disease
02/06/2008EP1883708A1 Genemap of the human genes associated with crohn's disease
02/06/2008EP1883645A1 Derivatives of 4-or 5-aminosalicylic acid
02/06/2008EP1883422A2 Tcr-independent activation of t cells
02/06/2008EP1339712B1 3-substituted quinuclidines and their use as nicotinic agonists
02/06/2008EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases
02/06/2008EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation
02/06/2008CN101119990A (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics
02/06/2008CN101119986A Optically active tetrahydronaphthalene derivative
02/06/2008CN101119728A Indolomorphinan derivative having carboxy in 6'-position
02/06/2008CN101117627A Pig epidemic diarrhea virus attenuated vaccine strain and uses thereof
02/06/2008CN101116750A Canine adenovirus DNA vaccines pVAX1-CpG-Loop
02/06/2008CN101116747A Cytosine arabinoside and gland correlated virus composite preparations and uses thereof
02/06/2008CN101116739A Chinese traditional medicine for treating acute and chronic hepatitis
02/06/2008CN101116726A Oral Chinese traditional medicine composition for treating constipation
02/06/2008CN101116723A Chinese traditional medicine for treating recurrent aphthous ulceration
02/06/2008CN101116702A Chinese traditional medicine composition for treating gastritis
02/06/2008CN101116687A Chinese traditional medicine pills for treating small intestine hernia and testis turgescence
02/06/2008CN101116673A Middle gut positioning sausage dissolvable pharmaceutical formulations for relieving diarrhea and processes for their preparation
02/06/2008CN101116466A Health-care tea for fat-reducing liver-fortifying and its preparing process thereof
02/06/2008CN100366723C Medicinal wine
02/06/2008CN100366722C Dispense of nourishing medicated wine
02/06/2008CN100366721C Mild wine with aloe as main traditional-Chinese-drug raw material and its production method and use
02/06/2008CN100366614C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
02/06/2008CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments
02/06/2008CN100366295C Composition for intestinal delivery
02/06/2008CN100366288C Dental ulcerative glue
02/06/2008CN100366282C Medicinal compositions comprising biphenyldicarboxylate
02/06/2008CN100366275C Method for controlling quality of Yunnan red tablet
02/06/2008CN100366260C Astragalus glycoside fatty emulsion and its preparation technology
02/06/2008CN100366241C Use of an IBAT inhibitor for the treatment of prophylaxis of constipation.
02/06/2008CN100366238C Freeze dried polyene lecithin powder for injection and its prepn
02/05/2008US7326801 2-amino-propanol derivatives
02/05/2008US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance
02/05/2008US7326730 Aminoadamantane derivatives as therapeutic agents
02/05/2008US7326724 Salts of omeprazole and esomeprazole I
02/05/2008US7326723 Autoimmune disease; antiinflammatory agents
02/05/2008US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy
02/05/2008US7326718 8-Substituted imidazopyridines